SYNH - Syneos Health Inc - Class A
Close
42.98
0.010 0.023%
Share volume: 0
Last Updated: Wed 27 Sep 2023 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$42.97
0.01
0.02%
Fundamental analysis
17%
Profitability
13%
Dept financing
40%
Liquidity
14%
Performance
16%
Performance
5 Days
0.14%
1 Month
0.52%
3 Months
6.92%
6 Months
11.12%
1 Year
-37.51%
2 Year
-51.32%
Key data
Stock price
$42.98
DAY RANGE
N/A - N/A
52 WEEK RANGE
$22.89 - $71.68
52 WEEK CHANGE
-$0.38
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Michael Bell
Region: US
Website:
Employees: 23,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 23,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Recent news